The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
Open accessAbstract
Drug discovery relies on the knowledge of not only drugs and targets, but also the comparative agents and targets. These include poor binders and non-binders for developing discovery tools, prodrugs for improved therapeutics, co-targets of therapeutic targets for multi-target strategies and off-target investigations, and the collective structure-activity and drug-likeness landscapes of enhanced drug feature. However, such valuable data are inadequately covered by the available databases. In this study, a major update of the Therapeutic Target Database, previously featured in NAR, was therefore introduced. This update includes (a) 34 861 poor binders and 12 683 non-binders of 1308 targets; (b) 534 prodrug-drug pairs for 121 targets; (c) 1127 co-targets of 672 targets regulated by 642 approved and 624 clinical trial drugs; (d) the collective structure-activity landscapes of 427 262 active agents of 1565 targets; (e) the profiles of drug-like properties of 33 598 agents of 1102 targets. Moreover, a variety of additional data and function are provided, which include the cross-links to the target structure in PDB and AlphaFold, 159 and 1658 newly emerged targets and drugs, and the advanced search function for multi-entry target sequences or drug structures. The database is accessible without login requirement at: https://idrblab.org/ttd/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Database resources of the National Center for Biotechnology Information: update
Wheeler, D. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,641
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051256o · Cited by 6,851
UniProt: the universal protein knowledgebase in 2021
The UniProt Consortium, Bateman, A., Martin, M.-J., Orchard, S., Magrane, M., Agivetova, R., Ahmad, S., Alpi, E., Bowler-Barnett, E. H., Britto, R., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1100 · Cited by 6,372
Lead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
PubChem in 2021: new data content and improved web interfaces
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa971 · Cited by 3,953
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Bostock, M., Ogievetsky, V., & Heer, J. (2011) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2011.185 · Cited by 3,165
Cited by
Olson, R. D., Assaf, R., Brettin, T., Conrad, N., Cucinell, C., Davis, J. J., Dempsey, D. M., Dickerman, A., Dietrich, E. M., Kenyon, R. W., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1003 · Cited by 1,260
Self-citationTTD: Therapeutic Target Database describing target druggability information
Zhou, Y., Zhang, Y., Zhao, D., Yu, X., Shen, X., Zhou, Y., Wang, S., Qiu, Y., Chen, Y., & Zhu, F. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad751 · Cited by 645
Self-citationSuperPred 3.0: drug classification and target prediction—a machine learning approach
Gallo, K., Goede, A., Preißner, R., & Gohlke, B.-O. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac297 · Cited by 414
Deep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Aboul Ella, H., Elshaier, Y. A. M. M., Gomaa, M. M., & Hassanien, A. E. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 390
Ren, F., Ding, X., Zheng, M., Korzinkin, M., Cai, X., Zhu, W., Mantsyzov, A., Aliper, A., Aladinskiy, V., Cao, Z., et al. (2023) · Chemical Science · doi:10.1039/d2sc05709c · Cited by 365
AI-powered therapeutic target discovery
Pun, F. W., Ozerov, I. V., & Zhavoronkov, A. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.06.010 · Cited by 341
Network pharmacology approaches for research of Traditional Chinese Medicines
LI, X., LIU, Z., LIAO, J., CHEN, Q., LU, X., & FAN, X. (2023) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(23)60429-7 · Cited by 308
Polypharmacology: The science of multi-targeting molecules
Kabir, A., & Muth, A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2021.106055 · Cited by 221
Li, L., Yang, L., Yang, L., He, C., He, Y., Chen, L., Dong, Q., Zhang, H., Chen, S., & Li, P. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00853-2 · Cited by 206
Kong, X., Liu, C., Zhang, Z., Cheng, M., Mei, Z., Li, X., Liu, P., Diao, L., Ma, Y., Jiang, P., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad926 · Cited by 205
Zerihun, M., Sukumaran, S., & Qvit, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065785 · Cited by 184
The landscape of small-molecule prodrugs
Fralish, Z., Chen, A., Khan, S. M., Zhou, P., & Reker, D. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00914-7 · Cited by 183
Han, R., Yoon, H., Kim, G., Lee, H., & Lee, Y. (2023) · Pharmaceuticals · doi:10.3390/ph16091259 · Cited by 176
DrugRep: an automatic virtual screening server for drug repurposing
Gan, J.-H., Liu, J., Liu, Y., Chen, S., Dai, W., Xiao, Z. J., & Cao, Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00996-2 · Cited by 160
Artificial Intelligence in Pharmaceutical Sciences
Lu, M., Yin, J., Zhu, Q., Lin, G., Mou, M., Liu, F., Pan, Z., You, N., Lian, X., Li, F., et al. (2023) · Engineering · doi:10.1016/j.eng.2023.01.014 · Cited by 156
Self-citationRevolutionizing Drug Discovery: A Comprehensive Review of AI Applications
Dhudum, R., Ganeshpurkar, A., & Pawar, A. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010009 · Cited by 157
AI empowering traditional Chinese medicine?
Song, Z., Chen, G., & Chen, C. Y. (2024) · Chemical Science · doi:10.1039/d4sc04107k · Cited by 142
The Role of AI in Drug Discovery
Abbas, M. K. G., Rassam, A., Karamshahi, F., Abunora, R., & Abouseada, M. (2024) · ChemBioChem · doi:10.1002/cbic.202300816 · Cited by 140
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Tanoli, Z., Fernández‐Torras, A., Özcan, U. O., Kushnir, A., Nader, K. M., Gadiya, Y., Fiorenza, L., Ianevski, A., Vähä-Koskela, M. J. V., Miihkinen, M., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01164-x · Cited by 122
Lu, Z., Song, G., Zhu, H., Lei, C., Sun, X., Wang, K., Qin, L., Chen, Y., Tang, J. P., & Li, M. (2025) · Nature Communications · doi:10.1038/s41467-025-57828-0 · Cited by 120
Self-citationNew drug discovery and development from natural products: Advances and strategies
Wang, Y., Wang, F., Liu, W., Geng, Y., Shi, Y., Yu, T., Zhang, B., Luo, Y., & Sun, X. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108752 · Cited by 111
From genetic associations to genes: methods, applications, and challenges
Qi, T., Song, L., Guo, Y., Chen, C., & Yang, J. (2024) · Trends in Genetics · doi:10.1016/j.tig.2024.04.008 · Cited by 102
DrugMAP: molecular atlas and pharma-information of all drugs
Li, F., Yin, J., Lu, M., Mou, M., Li, Z., Zeng, Z., Tan, Y. C., Wang, S., Chu, X., Dai, H., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac813 · Cited by 93
Self-citationMoringa oleifera Lam.: a comprehensive review on active components, health benefits and application
Su, X., Lu, G., Liang, Y., Shi, R., Zhu, M., Yu, X., Li, Z., Jia, X., & Feng, L. (2023) · RSC Advances · doi:10.1039/d3ra03584k · Cited by 90
Application of artificial intelligence in drug design: A review
Singh, S., Kaur, N., & Gehlot, A. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108810 · Cited by 88
ADCdb: the database of antibody–drug conjugates
Shen, L., Sun, X., Chen, Z., Guo, Y., Shen, Z., Song, Y., Xin, W., Ding, H., Ma, X., Xu, W., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad831 · Cited by 86
Self-citationDRESIS: the first comprehensive landscape of drug resistance information
Sun, X., Zhang, Y., Li, H., Zhou, Y., Shi, S., Chen, Z., He, X., Zhang, H., Li, F., Yin, J., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac812 · Cited by 81
Self-citationKanoni, S., Graham, S. E., Wang, Y., Surakka, I. L., Ramdas, S., Zhu, X., Clarke, S. L., Bhatti, K. F., Vedantam, S., Winkler, T. W., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02837-1 · Cited by 78
Pirolli, D., Righino, B., Camponeschi, C., Ria, F., Sante, G. D., & Rosa, M. C. D. (2023) · Scientific Reports · doi:10.1038/s41598-023-28716-8 · Cited by 76
Shirai, Y., Nakanishi, Y., Suzuki, A., Konaka, H., Nishikawa, R., Sonehara, K., Namba, S., Tanaka, H., Masuda, T., Yaga, M., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2022-222460 · Cited by 73
Yang, L., Wang, H., Zhu, Z., Yang, Y. G., Xiong, Y., Cui, X., & Liu, Y. (2025) · Pharmaceuticals · doi:10.3390/ph18071074 · Cited by 72
The 2022Nucleic Acids Researchdatabase issue and the online molecular biology database collection
Rigden, D. J., & Fernández, X. M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1195 · Cited by 71
Pandiyan, S., & Wang, L. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106140 · Cited by 70
Single cell landscape of parietal epithelial cells in healthy and diseased states
Liu, W., Huang, G., Liu, B., Hu, H., Geng, J., Rui, H., Gao, C. J., Huang, Y., Huo, G.-Y., Mao, J., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.03.036 · Cited by 62
Liu, Y., Li, X., Chen, C., Ding, N., Ma, S., & Yang, M. S. (2024) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2023.09.008 · Cited by 62
Ruan, G., Ye, L., Lin, J., Lin, H., Yu, L., Wang, C., Mao, X., Zhang, S., & Sun, P. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04048-z · Cited by 58
Self-citationAllosteric drugs: New principles and design approaches
Tee, W.-V., & Berezovsky, I. N. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102758 · Cited by 58
Metabolomics‐driven approaches for identifying therapeutic targets in drug discovery
Pan, S., Yin, L., Liu, J., Tong, J., Wang, Z., Zhao, J., Liu, X., Chen, Y., Miao, J., Zhou, Y., et al. (2024) · MedComm · doi:10.1002/mco2.792 · Cited by 59
Self-citationGenome-scale CRISPR screens identify host factors that promote human coronavirus infection
Grodzki, M., Bluhm, A. P., Schaefer, M., Tagmount, A., Russo, M., Sobh, A., Rafiee, R., Vulpe, C. D., Karst, S. M., & Norris, M. H. (2022) · Genome Medicine · doi:10.1186/s13073-022-01013-1 · Cited by 58
Weng, J., Wu, X.-F., Shao, P., Liu, X.-P., & Wang, C. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2299352 · Cited by 57
Self-citationMYCN and Metabolic Reprogramming in Neuroblastoma
Bansal, M., Gupta, A., & Ding, H. (2022) · Cancers · doi:10.3390/cancers14174113 · Cited by 54
Review of Predicting Synergistic Drug Combinations
Pan, Y., Ren, H., Lan, L., Li, Y., & Huang, T. (2023) · Life · doi:10.3390/life13091878 · Cited by 54
Evaluating the causal effect of circulating proteome on the risk of osteoarthritis-related traits
Zhang, Y., Xie, J., Wen, S., Cao, P., Xiao, W., Zhu, J., Li, S., Wang, Z., Cen, H., Zhu, Z., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224459 · Cited by 52
Self-citationXu, Z., Yang, L., Pi, P., Yi, Y., Tang, H., Zhang, Z., Xiong, H., Lei, B., Shi, Y., Li, J., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155817 · Cited by 51
Zhu, M., He, Q., Wang, Y., Duan, L., Rong, K., Wu, Y., Ding, Y., Mi, Y., Ge, X., Yang, X., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1238841 · Cited by 50
Guan, S., & Wang, G. (2024) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2024.100070 · Cited by 50
Soylu, N. N., & Sefer, E. (2023) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2023.3237769 · Cited by 48
Network-based drug repurposing for HPV-associated cervical cancer
Ahmed, F., Yang, Y. J., Samantasinghar, A., Kim, Y., Ko, J.-B., & Choi, K. H. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.038 · Cited by 48
Ren, A., Wu, T., Wang, Y., Fan, Q., Yang, Z., Zhang, S., Cao, Y., & Cui, G. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00814-9 · Cited by 48
Yang, J., Li, Z., Wu, W. K. K., Shi, Y., Xu, Z., Chu, Q., & Zhang, Q. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac469 · Cited by 46
An integrative analysis reveals cancer risk associated with artificial sweeteners
Xie, J., Zhu, Y., Yang, Z., Zhang, Y. L., Yang, M., & Wang, Q. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-06047-0 · Cited by 46
Self-citationQuinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design
Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · Pharmaceuticals · doi:10.3390/ph18050607 · Cited by 43
Bavachinin Ameliorates Rheumatoid Arthritis Inflammation via PPARG/PI3K/AKT Signaling Pathway
Deng, H., Jiang, J., Shu, J., Huang, M., Zhang, Q., Wu, L., & Sun, W. (2023) · Inflammation · doi:10.1007/s10753-023-01855-w · Cited by 43
MeDBA: the Metalloenzyme Data Bank and Analysis platform
Yu, J., Wu, S., Zhou, C., Dai, Q.-Q., Schofield, C. J., & Li, G. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac860 · Cited by 42
Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines
Zhang, W., Zheng, X., Coghi, P. S., Chen, J.-H., Dong, B.-J., & Fan, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1438030 · Cited by 42
Exhaustive local chemical space exploration using a transformer model
Tibo, A., He, J., Janet, J. P., Nittinger, E., & Engkvist, O. (2024) · Nature Communications · doi:10.1038/s41467-024-51672-4 · Cited by 42
Tan, Z., Gong, X., Wang, C. C., Zhang, T., & Huang, J. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115967 · Cited by 41
Self-citationNetwork approaches for modeling the effect of drugs and diseases
Rintala, T., Ghosh, A., & Fortino, V. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac229 · Cited by 41
Advances in machine intelligence‐driven virtual screening approaches for big‐data
Kumar, N., & Acharya, V. (2023) · Medicinal Research Reviews · doi:10.1002/med.21995 · Cited by 41
MBROLE3: improved functional enrichment of chemical compounds for metabolomics data analysis
López-Ibáñez, J., Pazos, F., & Chagoyen, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad405 · Cited by 39
Yao, M., Miller, G. W., Vardarajan, B. N., Baccarelli, A., Guo, Z., & Liu, Z. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100700 · Cited by 39
Privileged heterocycles for DNA-encoded library design and hit-to-lead optimization
Wen, X., Wu, X., Jin, R., & Lu, X. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.115079 · Cited by 39
Xu, J., Ding, Y., Shi, C., Yuan, F., Sheng, X., Liu, Y., Xie, Y., Lü, H., Duan, C., Hu, J., et al. (2024) · Aging and Disease · doi:10.14336/ad.2023.0509 · Cited by 39
Liu, A., Fernandes, B. S., Citu, C., & Zhao, Z. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01372-w · Cited by 39
Zhang, H., Han, Y., Xiao, W., Gao, Y., Sui, Z., Ren, P., Meng, F., Tang, P., & Yu, Z. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06259-0 · Cited by 38
M6AREG: m6A-centered regulation of disease development and drug response
Liu, S., Chen, L., Zhang, Y., Zhou, Y., He, Y., Chen, Z., Qi, S., Zhu, J., Chen, X., Zhang, H., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac801 · Cited by 38
Self-citationFan, M., Jin, C., Li, D., Deng, Y., Lin, Y., Chen, Y., Ma, Y., & Wang, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1289901 · Cited by 37
Self-citationProgress of AI-Driven Drug–Target Interaction Prediction and Lead Optimization
Wang, Q., Sun, B., Yi, Y., Velkov, T., Shen, J., Dai, C., & Jiang, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010037 · Cited by 37
Sun, T., Zhao, H., Hu, L., Shao, X., Lu, Z., Wang, Y., Ling, P., Li, Y., Zeng, K., & Chen, Q. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.01.018 · Cited by 36
Desai, T. A., Hedman, Å. K., Dimitriou, M., Koprulu, M., Figiel, S., Yin, W., Johansson, M., Watts, E. L., Atkins, J. R., Sokolov, A. V., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105168 · Cited by 36
Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders
Truong, T. T. T., Panizzutti, B., Kim, J. H., & Walder, K. R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071464 · Cited by 36
He, H., Duo, H., Hao, Y., Zhang, X., Zhou, X., Zeng, Y., Li, Y., & Li, B. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106671 · Cited by 36
In silico toxicity studies of traditional Chinese herbal medicine: A mini review
Zulkifli, M. H., Abdullah, Z. L., Yusof, N. I. S. M., & Fauzi, F. M. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102588 · Cited by 36
Mijit, A., Wang, X., Li, Y., Xu, H., Chen, Y., & Xue, W. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107183 · Cited by 36
Self-citationWen, J., Yang, Z., Nasrallah, I. M., Cui, Y., Erus, G., Srinivasan, D., Abdulkadir, A., Mamourian, E., Skampardoni, I., Hwang, G., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03121-5 · Cited by 36
Deep learning methods for protein structure prediction
Qin, Y., Chen, Z., Ye, P., Xiao, Y., Zhong, T., & Yu, X. (2024) · MedComm – Future Medicine · doi:10.1002/mef2.96 · Cited by 35
Sarker, P., Mitro, A., Hoque, H., Hasan, M. N., & Jewel, G. M. N. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107436 · Cited by 35
Cation-independent mannose 6-phosphate receptor: From roles and functions to targeted therapies
Gauthier, C., Cheikh, K. E., Basile, I., Daurat, M., Morère, E., Garcia, M., Maynadier, M., Morère, A., & Gary‐Bobo, M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.014 · Cited by 34
TarKG: a comprehensive biomedical knowledge graph for target discovery
Zhou, C., Cai, C., Huang, X., Wu, S., Yu, J., Wu, J., Fang, J., & Li, G. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae598 · Cited by 34
Wu, J., Xiao, Y., Lin, M., Cai, H., Zhao, D., Li, Y., Luo, H., Tang, C., & Wang, L. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115401 · Cited by 34
Chen, Y., Zhang, F., Sun, J., & Zhang, L. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04755-7 · Cited by 33
Self-citationIn silico drug discovery: a machine learning-driven systematic review
Atasever, S. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03260-w · Cited by 33
Li, Q.-F., Lu, W.-T., Zhang, Q., Zhao, Y., Wu, C., & Zhou, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.773537 · Cited by 33
Singh, V., Naldi, A., Soliman, S., & Niarakis, A. (2023) · npj Systems Biology and Applications · doi:10.1038/s41540-023-00294-5 · Cited by 33
VARIDT 3.0: the phenotypic and regulatory variability of drug transporter
Yin, J., Chen, Z., You, N., Li, F., Zhang, H., Jia, X., Ma, H., Zhao, Q. D., Yu, L., Zeng, S., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad818 · Cited by 33
Self-citationYan, T., Yue, Z., Xu, H., Liu, Y., Hong, Y., Chen, G.-X., Tao, L., & Xie, T. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106446 · Cited by 32
Hou, D., Lin, H., Feng, Y., Zhou, K., Li, X., Yang, Y., Wang, S., Yang, X., Wang, J., Zhao, H., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad921 · Cited by 31
Self-citationAI-Based Computational Methods in Early Drug Discovery and Post Market Drug Assessment: A Survey
Rajaei, F., Minoccheri, C., Wittrup, E. M., Wilson, R. C., Athey, B. D., Omenn, G. S., & Najarian, K. (2024) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2024.3492708 · Cited by 31
Network pharmacology of iridoid glycosides from Eucommia ulmoides Oliver against osteoporosis
Wang, T., Fan, L., Feng, S., Ding, X., An, X., Chen, J., Wang, M., Zhai, X., & Li, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-10769-w · Cited by 31
Shi, L., Zhao, Y., Feng, C., Miao, F., Dong, L., Wang, T., Stalin, A., Zhang, J., Tu, J., Liu, K., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.967164 · Cited by 31
Yang, N., Shao, H., Deng, J., & Liu, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116023 · Cited by 31
Yang, H., Liu, C., Lin, X., Li, X., Zeng, S., Gong, Z., Xu, Q., Li, D., & Li, N. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109965 · Cited by 31
The Knowns and Unknowns in Protein–Metabolite Interactions
Kurbatov, I. Y., Dolgalev, G. V., Arzumanian, V. A., Kiseleva, O. I., & Poverennaya, E. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044155 · Cited by 30
Jo, H.-G., Baek, C. Y., Kim, D.-H., Kim, S. J., Han, Y., Park, C., Song, H. S., & Lee, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1282943 · Cited by 30
Ackerman, W. E., Buhimschi, C. S., Brown, T. L., Zhao, G., Summerfield, T. L. S., & Buhimschi, I. A. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20807 · Cited by 29
Application of artificial intelligence large language models in drug target discovery
Liu, X., Zhang, J., Wang, X., Teng, M., Wang, G., & Zhou, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1597351 · Cited by 29
Wang, X., Huang, T., & Jia, J. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029003 · Cited by 29
DrugRepoBank: a comprehensive database and discovery platform for accelerating drug repositioning
Huang, Y., Dong, D., Zhang, W., Wang, R., Lin, Y.-C.-D., Zuo, H., Huang, H., & Huang, H. (2024) · Database · doi:10.1093/database/baae051 · Cited by 29
Li, J., Li, T., Li, Z., Song, Z., & Gong, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1154743 · Cited by 28
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safety
Goldring, C. E., Russomanno, G., Pin, C., Trairatphisan, P., Beattie, K. A., Fisher, C., Piñero, J., Brennan, R., Clausznitzer, D., Copple, I. M., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01308-z · Cited by 27
Metadata
- Authors
- Zhou, Y., Zhang, Y., Lian, X., Li, F., Wang, C., Zhu, F., Qiu, Y., & Chen, Y.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-10-28
- Volume
- 50
- Issue
- D1
- Pages
- D1398-D1407
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W3210331473
- Cited by
- 665
- References
- 85
- FWCI
- 67.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.